Literature DB >> 16914326

The role of the NKG2D receptor for tumor immunity.

Jérôme D Coudert1, Werner Held.   

Abstract

Natural killer (NK) cells have originally been identified based on their capacity to kill transformed cells in a seemingly non-specific fashion. Over the last 15 years, knowledge on receptor ligand systems used by NK cells to specifically detect transformed cells has been accumulating rapidly. One of these receptor ligand systems, the NKG2D pathway, has received particular attention, and now serves as a paradigm for how the immune system is able to gather information about the health status of autologous host cells. In addition to its significance on NK cells, NKG2D, as well as other NK cell receptors, play significant roles on T cells. This review aims at summarizing recent insights into the regulation of NKG2D function, the control over NKG2D ligand expression and the role of NKG2D in tumor immunity. Finally, we will discuss first attempts to exploit NKG2D function to improve immunity to tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914326     DOI: 10.1016/j.semcancer.2006.07.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  49 in total

1.  DNA methylation in nasal epithelial cells from smokers: identification of ULBP3-related effects.

Authors:  Julia E Rager; Rebecca N Bauer; Loretta L Müller; Lisa Smeester; Johnny L Carson; Luisa E Brighton; Rebecca C Fry; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-07-05       Impact factor: 5.464

2.  Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.

Authors:  Giovanni F Torelli; Nadia Peragine; Sara Raponi; Daria Pagliara; Maria S De Propris; Antonella Vitale; Alice Bertaina; Walter Barberi; Lorenzo Moretta; Giuseppe Basso; Angela Santoni; Anna Guarini; Franco Locatelli; Robin Foà
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

3.  p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells.

Authors:  Alessandra Soriani; Cristiana Borrelli; Biancamaria Ricci; Rosa Molfetta; Alessandra Zingoni; Cinzia Fionda; Silvia Carnevale; Maria Pia Abruzzese; Maria Teresa Petrucci; Maria Rosaria Ricciardi; Giuseppe La Regina; Erica Di Cesare; Patrizia Lavia; Romano Silvestri; Rossella Paolini; Marco Cippitelli; Angela Santoni
Journal:  Oncoimmunology       Date:  2016-12-02       Impact factor: 8.110

Review 4.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

5.  Genetic variation of the natural killer gene complex has a role in lung cancer susceptibility.

Authors:  Ryan W Logan; Dipak K Sarkar
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

6.  Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.

Authors:  Maulik Vyas; Ann-Charlott Schneider; Olga Shatnyeva; Katrin S Reiners; Samir Tawadros; Stephan Kloess; Ulrike Köhl; Michael Hallek; Hinrich P Hansen; Elke Pogge von Strandmann
Journal:  Oncoimmunology       Date:  2016-07-15       Impact factor: 8.110

7.  A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.

Authors:  Giovanni F Torelli; Carmela Rozera; Laura Santodonato; Nadia Peragine; Giuseppina D'agostino; Enrica Montefiore; Maria R Napolitano; Domenica M Monque; Davide Carlei; Paola Mariglia; Simona Pauselli; Maria Gozzer; Mahnaz Shafii Bafti; Gabriella Girelli; Anna Guarini; Filippo Belardelli; Robin Foà
Journal:  Blood Transfus       Date:  2015-01-30       Impact factor: 3.443

8.  In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.

Authors:  Ryosei Nishimura; Jeanette Baker; Andreas Beilhack; Robert Zeiser; Janelle A Olson; Emanuela I Sega; Mobin Karimi; Robert S Negrin
Journal:  Blood       Date:  2008-06-18       Impact factor: 22.113

9.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

10.  Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Authors:  Robert A Eagle; Insiya Jafferji; Alexander D Barrow
Journal:  Curr Immunol Rev       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.